Eurograd message

Message posted on 11/07/2022

For mailing list - webinar announcement


"Should we delete our apps?" Reproductive Health and Data Privacy July 19th, 1800 (GMT)

For more information and to register:

Or email:

Following the decision of the Supreme Court, and over the last few weeks, news and social media have been flooded with calls for women to delete their menstruation, ovulation, or pregnancy apps. As part of a larger spectrum of womens digital health products the industry known as FemTech tracking apps that help to manage womens sexual and reproductive health have come under fire in the wake of Roe v. Wade for their data management practices. These fears are not unfounded in December 2018, for instance, London-based charity Privacy International reported that many well-known menstruation apps were regularly sharing user data with social media channels. Of the 36 applications they tested, more than 61% immediately transferred data to Facebook when a user opened the app. This is not just a challenge for startups. Indeed, recently the ovulation app Flo reached a settlement with the Federal Trade Commission after allowing the data accumulated by its almost 100 million users to be shared with third party companies, including advertisers (Singer, 2021).

Where then, is the balance? We know that during the pandemic, women turned more than ever to technology for their health needs and now, with the fears around accessing reproductive services in traditional settings, FemTech still has a critical role to play in bringing digital tools to the women who need them most. And so the question is not so much how can we delete our apps, but, rather, how do I know which apps are data secure, safe, and medically accurate? If FemTech data is crucial for both the advancement of medical research and accuracy, as well as for responsible innovation, how do we ensure that same data is being safeguarded against data brokerage to third party advertisers and government enforcement agencies?

While recent events have been centred in the United States, the concerns around surveillance and retribution are global. Reproductive rights are under threat around the world and FemTech has a unique opportunity to provide safe and accessible digital healthcare that is innovative and data secure.

Join us for a conversation with legal experts, scholars, FemTech founders, and regulatory bodies to answer the question: How can womens intimate health data be protected in the fight for reproductive justice?


Bethany Corbin, Esq., Senior Counsel at Nixon Gwilt Law

Dr Simon Leigh, PhD. Director of Research, Organisation for the Review of Care and Health Apps

Danika Kelly, MA. CEO, My Normative

Dr Samantha Lattof, PhD. CEO, Maila Health

Only registered participants will received details to join.

Dr. Lindsay Balfour Assistant Professor of Digital Media Centre for Postdigital Cultures Coventry University



Queen's Award for Enterprise International Trade 2022

Ranked in the top 50% of UK universities for research power Times Higher Education analysis of REF 2021

Joint top Modern University for Career Prospects Guardian University Guide 2022

Top 30 in the World for International Students(ratio) QS World University Rankings 2022


This message and any files transmitted with it is intended for the addressee only and may contain information that is confidential or privileged. Unauthorised use is strictly prohibited. If you are not the addressee, you should not read, copy, disclose or otherwise use this message, except for the purpose of delivery to the addressee.

Any views or opinions expressed within this e-mail are those of the author and do not necessarily represent those of Coventry University.

EASST's Eurograd mailing list Eurograd (at) Unsubscribe or edit subscription options:

Meet us via

Report abuses of this list to

view as plain text
Follow by Email